PHARMACEUTICAL ECONSULTING A/S: Financial statements 2022
CVR: 30815378
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
PHARMACEUTICAL ECONSULTING A/S (CVR 30815378) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 6,778,724 and a net result of DKK 779,620 compared with DKK 2,419,807 the year before. That is a decrease of 18.1% compared with the year before. Equity in the 2022 report amounted to DKK 7,247,050. The solvency ratio was 89.6%. The company had 8 employees in the financial year.
- Gross Profit
- DKK 6,778,724
- Profit/Loss
- DKK 779,620
- Equity
- DKK 7,247,050
- Total Assets
- DKK 8,092,290
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 6.8M | 780K | 7.2M | 8 |
| 2021 | - | 8.3M | 2.4M | 6.5M | 5 |
| 2020 | - | 6.9M | 2.3M | 4M | 4 |
| 2019 | - | 5.3M | 1.2M | 2.7M | 4 |
| 2018 | - | 3.8M | 1.1M | 2.5M | 4 |
Official annual report
Keep an eye on PHARMACEUTICAL ECONSULTING A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2021. Gross profit came to DKK 8,276,389, and the net result was DKK 2,419,807.
About PHARMACEUTICAL ECONSULTING A/S
PHARMACEUTICAL ECONSULTING A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2007. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Steen Otto Rugaard. The board consists of Pernille Laurberg Rugaard (chair), Hanne Laurberg Olesen and Steen Otto Rugaard. The company is owned by RUGAARD HOLDING ApS. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. Equity in the 2025 report amounted to DKK 5,152,605.